InvestorsHub Logo
Followers 197
Posts 24669
Boards Moderated 0
Alias Born 04/03/2010

Re: exwannabe post# 692698

Monday, 05/20/2024 9:53:51 AM

Monday, May 20, 2024 9:53:51 AM

Post# of 700005
Getting a license for and maintaining a facility, which Advent does for NWBO so that it can ultimately get licensed to market and sell and manufacture its drug, is ALWAYS going to be expensive. That is a drop in the bucket given what companies spend. Dendreon went bankrupt developing such facilities for itself, and this is EXACTY what shorts counted on for NWBO. She found a way around this and shorts can't help but try to imply there is something wrong with her being able to ultimately destroy their previous argument against and practical challenge to this endeavor, that they thought would kill any new dendritic cell vaccine company. SHORTS failed to comprehend DCVax-L and why it was different, Shorts assumed things that were flat out wrong, and now they can do nothing but throw stones constantly because they have nothing.

You've got zero, nothing, nada. You can only attack by implying false notions and taking facts out of context and hoping naive rubes will believe your nonsense.

That cost would have been hundreds of millions of dollars up front previously. $15 million is an amazing accomplishment and thanks for laying it out. Literally people pay many times more for apartments in NYC. This is a new treatment for cancers that will open up a whole new pathway to potential cures.


https://www.nytimes.com/2019/01/24/business/who-is-ken-griffin.html?unlocked_article_code=1.tU0.DqBk.b2s6-6fanSQ6&smid=url-share

The Hedge Fund Manager Who Just Paid $238 Million for a Manhattan Penthouse
Here’s what else we know about the billionaire Kenneth Griffin and how he spends his money (besides buying New York’s most expensive apartment). Jan. 24, 2019


I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News